bioAffinity CEO to present at H.C. Wainwright Global Investment Conference - BIAF News | RalliesbioAffinity CEO to present at H.C. Wainwright Global Investment Conference
B
BIAF• CEO presentation and investor meetings
- bioAffinity Technologies CEO Maria Zannes will present at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026.
- The corporate update will address strategic milestones, commercial traction for the CyPath Lung test, and progress on its broader diagnostic platform.
- One-on-one meetings with investors are scheduled during the conference.
